22nd Century group, a biotech firm that specializes in the DNA reconstruction of tobacco plants to be used in the smoking cessation process announced yesterday that it has cleared the hurdles required to list on the NYSE, Virtu will be the DMM:
22nd Century Group, Inc. (OTCQB:XXII) today announced that the Company received approval to list its common stock on the NYSE MKT. Trading on the NYSE MKT is expected to commence on Tuesday, March 11, 2014 under the Company's current symbol, XXII. In connection with this NYSE MKT listing, 22nd Century Group will cease trading on the OTCBB and OTCQB. Read More Here22nd Century is locally based firm and aside from trying to find value looking at metrics growth or debt sensitivity will make you nuts. XXII has it's Alpha inside of it's technology, the same technology that was verified when British American Tobacco signed a business/re-licensing agreement.
I'm standing by this stock. I met with the management guys and seen both operations in Buffalo, haven't traveled to NASCO facility but this operation is legit and the technology is outrageously valuable. I would seriously consider your risk levels and take a gander at grabbing exposure sooner than later.
I'll cover more over the weekend. In the meantime, I'm takign today off and going shooting and riding out at my families land with a buddy. Enjoy NFP and Twitter Hate, at least I won't be there to add more to disintegration of Twitters effort to bring us together.
XXII Message Forum Board
